▶ 調査レポート

ホスホマイシントロメタモールのグローバル市場2021

• 英文タイトル:Global Fosfomycin Trometamol Sales Market Report 2021

QYResearchが調査・発行した産業分析レポートです。ホスホマイシントロメタモールのグローバル市場2021 / Global Fosfomycin Trometamol Sales Market Report 2021 / QAF21401資料のイメージです。• レポートコード:QAF21401
• 出版社/出版日:QYResearch / 2021年4月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、132ページ
• 納品方法:Eメール(即日納品)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界のホスホマイシントロメタモール市場について種類別(ホスホマイシントロメタミン顆粒、ホスホマイシントロメタミン粉末)、用途別(一般尿路感染症、手術後尿路感染症、手術前尿路感染症予防)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ホスホマイシントロメタモール市場の概要
・世界の主要地域別ホスホマイシントロメタモール市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のホスホマイシントロメタモール市場規模2016-2021:種類別(ホスホマイシントロメタミン顆粒、ホスホマイシントロメタミン粉末)
・世界のホスホマイシントロメタモール市場予測2012-2027:種類別(ホスホマイシントロメタミン顆粒、ホスホマイシントロメタミン粉末)
・世界のホスホマイシントロメタモール市場規模2016-2021:用途別(一般尿路感染症、手術後尿路感染症、手術前尿路感染症予防)
・世界のホスホマイシントロメタモール市場予測2012-2027:用途別(一般尿路感染症、手術後尿路感染症、手術前尿路感染症予防)
・ホスホマイシントロメタモールのアメリカ市場規模と予測2016-2021
・ホスホマイシントロメタモールのヨーロッパ市場規模と予測2016-2021
・ホスホマイシントロメタモールの中国市場規模と予測2016-2021
・ホスホマイシントロメタモールの日本市場規模と予測2016-2021
・ホスホマイシントロメタモールの東南アジア市場規模と予測2016-2021
・ホスホマイシントロメタモールのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Zambon、Northesat Pharm、Hunan Huana Pharmaceuticals、Xunda Pharma、FarmaSino Pharmaceutical、Guilin Hwasun)
・ホスホマイシントロメタモールの製造コスト分析
・販売チャネル、流通業者、顧客
・ホスホマイシントロメタモールの市場動向・機会・課題
・調査の結論

Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
In the last several years, global market of fosfomycin trometamol developed smoothly, with an average growth rate of 7.8%.

the global average price of fosfomycin trometamol is in the decreasing trend, from 131 USD /kg in 2011 to 124 USD/kg in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.

the classification of fosfomycin trometamol includes fosfomycin tromethamine granules and fosfomycin tromethamine powder, and the proportion of fosfomycin tromethamine granules in 2015 is about 56%.fosfomycin trometamol is widely used in urinary tract infection.

china is the largest supplier of fosfomycin trometamol, with a production market share nearly 83% in 2015. europe is the second largest supplier of fosfomycin trometamol, enjoying production market share nearly 15% in 2015.

north america is the largest consumption place, with a consumption market share nearly 36% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 31%. China is the world’s largest exporting country.

market competition is not intense. Zambon and northesat pharm, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Fosfomycin Trometamol Market
The global Fosfomycin Trometamol market was valued at US$ 54 in 2020 and will reach US$ 66 million by the end of 2027, growing at a CAGR of 3.3% during 2022-2027.

Global Fosfomycin Trometamol Scope and Market Size
The global Fosfomycin Trometamol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fosfomycin Trometamol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder

Segment by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection

The Fosfomycin Trometamol market is analysed and market size information is provided by regions (countries). Segment by Application, the Fosfomycin Trometamol market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun

レポート目次

1 Fosfomycin Trometamol Market Overview
1.1 Fosfomycin Trometamol Product Scope
1.2 Fosfomycin Trometamol Segment by Type
1.2.1 Global Fosfomycin Trometamol Sales by Type (2016 & 2021 & 2027)
1.2.2 Fosfomycin Tromethamine Granules
1.2.3 Fosfomycin Tromethamine Powder
1.3 Fosfomycin Trometamol Segment by Application
1.3.1 Global Fosfomycin Trometamol Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Common Urinary Tract Infection
1.3.3 Postoperative Urinary Tract Infection
1.3.4 Preoperative Prevention of Urinary Tract Infection
1.4 Fosfomycin Trometamol Market Estimates and Forecasts (2016-2027)
1.4.1 Global Fosfomycin Trometamol Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Fosfomycin Trometamol Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Fosfomycin Trometamol Price Trends (2016-2027)

2 Fosfomycin Trometamol Estimates and Forecasts by Region
2.1 Global Fosfomycin Trometamol Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Fosfomycin Trometamol Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Fosfomycin Trometamol Sales Market Share by Region (2016-2021)
2.2.2 Global Fosfomycin Trometamol Revenue Market Share by Region (2016-2021)
2.3 Global Fosfomycin Trometamol Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Fosfomycin Trometamol Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Fosfomycin Trometamol Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Fosfomycin Trometamol Estimates and Projections (2016-2027)
2.4.2 Europe Fosfomycin Trometamol Estimates and Projections (2016-2027)
2.4.3 China Fosfomycin Trometamol Estimates and Projections (2016-2027)
2.4.4 Japan Fosfomycin Trometamol Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Fosfomycin Trometamol Estimates and Projections (2016-2027)
2.4.6 India Fosfomycin Trometamol Estimates and Projections (2016-2027)
3 Global Fosfomycin Trometamol Competition Landscape by Players
3.1 Global Top Fosfomycin Trometamol Players by Sales (2016-2021)
3.2 Global Top Fosfomycin Trometamol Players by Revenue (2016-2021)
3.3 Global Fosfomycin Trometamol Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fosfomycin Trometamol as of 2020)
3.4 Global Fosfomycin Trometamol Average Price by Company (2016-2021)
3.5 Manufacturers Fosfomycin Trometamol Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Fosfomycin Trometamol Market Size by Type
4.1 Global Fosfomycin Trometamol Historic Market Review by Type (2016-2021)
4.1.1 Global Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
4.1.2 Global Fosfomycin Trometamol Revenue Market Share by Type (2016-2021)
4.1.3 Global Fosfomycin Trometamol Price by Type (2016-2021)
4.2 Global Fosfomycin Trometamol Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Fosfomycin Trometamol Sales Forecast by Type (2022-2027)
4.2.2 Global Fosfomycin Trometamol Revenue Forecast by Type (2022-2027)
4.2.3 Global Fosfomycin Trometamol Price Forecast by Type (2022-2027)
5 Global Fosfomycin Trometamol Market Size by Application
5.1 Global Fosfomycin Trometamol Historic Market Review by Application (2016-2021)
5.1.1 Global Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
5.1.2 Global Fosfomycin Trometamol Revenue Market Share by Application (2016-2021)
5.1.3 Global Fosfomycin Trometamol Price by Application (2016-2021)
5.2 Global Fosfomycin Trometamol Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Fosfomycin Trometamol Sales Forecast by Application (2022-2027)
5.2.2 Global Fosfomycin Trometamol Revenue Forecast by Application (2022-2027)
5.2.3 Global Fosfomycin Trometamol Price Forecast by Application (2022-2027)

6 North America Fosfomycin Trometamol Market Facts & Figures
6.1 North America Fosfomycin Trometamol Sales by Company
6.1.1 North America Fosfomycin Trometamol Sales by Company (2016-2021)
6.1.2 North America Fosfomycin Trometamol Revenue by Company (2016-2021)
6.2 North America Fosfomycin Trometamol Sales Breakdown by Type
6.2.1 North America Fosfomycin Trometamol Sales Breakdown by Type (2016-2021)
6.2.2 North America Fosfomycin Trometamol Sales Breakdown by Type (2022-2027)
6.3 North America Fosfomycin Trometamol Sales Breakdown by Application
6.3.1 North America Fosfomycin Trometamol Sales Breakdown by Application (2016-2021)
6.3.2 North America Fosfomycin Trometamol Sales Breakdown by Application (2022-2027)

7 Europe Fosfomycin Trometamol Market Facts & Figures
7.1 Europe Fosfomycin Trometamol Sales by Company
7.1.1 Europe Fosfomycin Trometamol Sales by Company (2016-2021)
7.1.2 Europe Fosfomycin Trometamol Revenue by Company (2016-2021)
7.2 Europe Fosfomycin Trometamol Sales Breakdown by Type
7.2.1 Europe Fosfomycin Trometamol Sales Breakdown by Type (2016-2021)
7.2.2 Europe Fosfomycin Trometamol Sales Breakdown by Type (2022-2027)
7.3 Europe Fosfomycin Trometamol Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Fosfomycin Trometamol Market Facts & Figures
8.1 China Fosfomycin Trometamol Sales by Company
8.1.1 China Fosfomycin Trometamol Sales by Company (2016-2021)
8.1.2 China Fosfomycin Trometamol Revenue by Company (2016-2021)
8.2 China Fosfomycin Trometamol Sales Breakdown by Type
8.2.1 China Fosfomycin Trometamol Sales Breakdown by Type (2016-2021)
8.2.2 China Fosfomycin Trometamol Sales Breakdown by Type (2022-2027)
8.3 China Fosfomycin Trometamol Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)

9 Japan Fosfomycin Trometamol Market Facts & Figures
9.1 Japan Fosfomycin Trometamol Sales by Company
9.1.1 Japan Fosfomycin Trometamol Sales by Company (2016-2021)
9.1.2 Japan Fosfomycin Trometamol Revenue by Company (2016-2021)
9.2 Japan Fosfomycin Trometamol Sales Breakdown by Type
9.2.1 Japan Fosfomycin Trometamol Sales Breakdown by Type (2016-2021)
9.2.2 Japan Fosfomycin Trometamol Sales Breakdown by Type (2022-2027)
9.3 Japan Fosfomycin Trometamol Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Fosfomycin Trometamol Market Facts & Figures
10.1 Southeast Asia Fosfomycin Trometamol Sales by Company
10.1.1 Southeast Asia Fosfomycin Trometamol Sales by Company (2016-2021)
10.1.2 Southeast Asia Fosfomycin Trometamol Revenue by Company (2016-2021)
10.2 Southeast Asia Fosfomycin Trometamol Sales Breakdown by Type
10.2.1 Southeast Asia Fosfomycin Trometamol Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Fosfomycin Trometamol Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Fosfomycin Trometamol Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Fosfomycin Trometamol Market Facts & Figures
11.1 India Fosfomycin Trometamol Sales by Company
11.1.1 India Fosfomycin Trometamol Sales by Company (2016-2021)
11.1.2 India Fosfomycin Trometamol Revenue by Company (2016-2021)
11.2 India Fosfomycin Trometamol Sales Breakdown by Type
11.2.1 India Fosfomycin Trometamol Sales Breakdown by Type (2016-2021)
11.2.2 India Fosfomycin Trometamol Sales Breakdown by Type (2022-2027)
11.3 India Fosfomycin Trometamol Sales Breakdown by Application
11.3.1 India Fosfomycin Trometamol Sales Breakdown by Application (2016-2021)
11.3.2 India Fosfomycin Trometamol Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Fosfomycin Trometamol Business
12.1 Zambon
12.1.1 Zambon Corporation Information
12.1.2 Zambon Business Overview
12.1.3 Zambon Fosfomycin Trometamol Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Zambon Fosfomycin Trometamol Products Offered
12.1.5 Zambon Recent Development
12.2 Northesat Pharm
12.2.1 Northesat Pharm Corporation Information
12.2.2 Northesat Pharm Business Overview
12.2.3 Northesat Pharm Fosfomycin Trometamol Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Northesat Pharm Fosfomycin Trometamol Products Offered
12.2.5 Northesat Pharm Recent Development
12.3 Hunan Huana Pharmaceuticals
12.3.1 Hunan Huana Pharmaceuticals Corporation Information
12.3.2 Hunan Huana Pharmaceuticals Business Overview
12.3.3 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Products Offered
12.3.5 Hunan Huana Pharmaceuticals Recent Development
12.4 Xunda Pharma
12.4.1 Xunda Pharma Corporation Information
12.4.2 Xunda Pharma Business Overview
12.4.3 Xunda Pharma Fosfomycin Trometamol Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Xunda Pharma Fosfomycin Trometamol Products Offered
12.4.5 Xunda Pharma Recent Development
12.5 FarmaSino Pharmaceutical
12.5.1 FarmaSino Pharmaceutical Corporation Information
12.5.2 FarmaSino Pharmaceutical Business Overview
12.5.3 FarmaSino Pharmaceutical Fosfomycin Trometamol Sales, Revenue and Gross Margin (2016-2021)
12.5.4 FarmaSino Pharmaceutical Fosfomycin Trometamol Products Offered
12.5.5 FarmaSino Pharmaceutical Recent Development
12.6 Guilin Hwasun
12.6.1 Guilin Hwasun Corporation Information
12.6.2 Guilin Hwasun Business Overview
12.6.3 Guilin Hwasun Fosfomycin Trometamol Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Guilin Hwasun Fosfomycin Trometamol Products Offered
12.6.5 Guilin Hwasun Recent Development

13 Fosfomycin Trometamol Manufacturing Cost Analysis
13.1 Fosfomycin Trometamol Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Fosfomycin Trometamol
13.4 Fosfomycin Trometamol Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Fosfomycin Trometamol Distributors List
14.3 Fosfomycin Trometamol Customers

15 Market Dynamics
15.1 Fosfomycin Trometamol Market Trends
15.2 Fosfomycin Trometamol Drivers
15.3 Fosfomycin Trometamol Market Challenges
15.4 Fosfomycin Trometamol Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Fosfomycin Trometamol Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Fosfomycin Trometamol Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Fosfomycin Trometamol Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Fosfomycin Trometamol Sales (K MT) by Region (2016-2021)
Table 5. Global Fosfomycin Trometamol Sales Market Share by Region (2016-2021)
Table 6. Global Fosfomycin Trometamol Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Fosfomycin Trometamol Revenue Share by Region (2016-2021)
Table 8. Global Fosfomycin Trometamol Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Fosfomycin Trometamol Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Fosfomycin Trometamol Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Fosfomycin Trometamol Revenue Share Forecast by Region (2022-2027)
Table 12. Global Fosfomycin Trometamol Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Fosfomycin Trometamol Sales Share by Company (2016-2021)
Table 14. Global Fosfomycin Trometamol Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Fosfomycin Trometamol Revenue Share by Company (2016-2021)
Table 16. Global Fosfomycin Trometamol by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fosfomycin Trometamol as of 2020)
Table 17. Global Fosfomycin Trometamol Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Fosfomycin Trometamol Manufacturing Sites and Area Served
Table 19. Manufacturers Fosfomycin Trometamol Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Fosfomycin Trometamol Sales (K MT) by Type (2016-2021)
Table 22. Global Fosfomycin Trometamol Sales Share by Type (2016-2021)
Table 23. Global Fosfomycin Trometamol Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Fosfomycin Trometamol Price (USD/MT) by Type (2016-2021)
Table 25. Global Fosfomycin Trometamol Sales Share by Type (2022-2027)
Table 26. Global Fosfomycin Trometamol Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Fosfomycin Trometamol Revenue Share by Type (2022-2027)
Table 28. Global Fosfomycin Trometamol Price (USD/MT) by Type (2022-2027)
Table 29. Global Fosfomycin Trometamol Sales (K MT) by Application (2016-2021)
Table 30. Global Fosfomycin Trometamol Sales Share by Application (2016-2021)
Table 31. Global Fosfomycin Trometamol Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Fosfomycin Trometamol Price (USD/MT) by Application (2016-2021)
Table 33. Global Fosfomycin Trometamol Sales (K MT) by Application (2022-2027)
Table 34. Global Fosfomycin Trometamol Sales Share by Application (2022-2027)
Table 35. Global Fosfomycin Trometamol Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Fosfomycin Trometamol Revenue Share by Application (2022-2027)
Table 37. Global Fosfomycin Trometamol Price (USD/MT) by Application (2022-2027)
Table 38. North America Fosfomycin Trometamol Sales (K MT) by Company (2016-2021)
Table 39. North America Fosfomycin Trometamol Sales Market Share by Company (2016-2021)
Table 40. North America Fosfomycin Trometamol Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Fosfomycin Trometamol Revenue Market Share by Company (2016-2021)
Table 42. North America Fosfomycin Trometamol Sales by Type (2016-2021) & (K MT)
Table 43. North America Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
Table 44. North America Fosfomycin Trometamol Sales by Type (2022-2027) & (K MT)
Table 45. North America Fosfomycin Trometamol Sales Market Share by Type (2022-2027)
Table 46. North America Fosfomycin Trometamol Sales by Application (2016-2021) & (K MT)
Table 47. North America Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
Table 48. North America Fosfomycin Trometamol Sales by Application (2022-2027) & (K MT)
Table 49. North America Fosfomycin Trometamol Sales Market Share by Application (2022-2027)
Table 50. Europe Fosfomycin Trometamol Sales (K MT) by Company (2016-2021)
Table 51. Europe Fosfomycin Trometamol Sales Market Share by Company (2016-2021)
Table 52. Europe Fosfomycin Trometamol Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Fosfomycin Trometamol Revenue Market Share by Company (2016-2021)
Table 54. Europe Fosfomycin Trometamol Sales by Type (2016-2021) & (K MT)
Table 55. Europe Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
Table 56. Europe Fosfomycin Trometamol Sales by Type (2022-2027) & (K MT)
Table 57. Europe Fosfomycin Trometamol Sales Market Share by Type (2022-2027)
Table 58. Europe Fosfomycin Trometamol Sales by Application (2016-2021) & (K MT)
Table 59. Europe Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
Table 60. Europe Fosfomycin Trometamol Sales by Application (2022-2027) & (K MT)
Table 61. Europe Fosfomycin Trometamol Sales Market Share by Application (2022-2027)
Table 62. China Fosfomycin Trometamol Sales (K MT) by Company (2016-2021)
Table 63. China Fosfomycin Trometamol Sales Market Share by Company (2016-2021)
Table 64. China Fosfomycin Trometamol Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Fosfomycin Trometamol Revenue Market Share by Company (2016-2021)
Table 66. China Fosfomycin Trometamol Sales by Type (2016-2021) & (K MT)
Table 67. China Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
Table 68. China Fosfomycin Trometamol Sales by Type (2022-2027) & (K MT)
Table 69. China Fosfomycin Trometamol Sales Market Share by Type (2022-2027)
Table 70. China Fosfomycin Trometamol Sales by Application (2016-2021) & (K MT)
Table 71. China Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
Table 72. China Fosfomycin Trometamol Sales by Application (2022-2027) & (K MT)
Table 73. China Fosfomycin Trometamol Sales Market Share by Application (2022-2027)
Table 74. Japan Fosfomycin Trometamol Sales (K MT) by Company (2016-2021)
Table 75. Japan Fosfomycin Trometamol Sales Market Share by Company (2016-2021)
Table 76. Japan Fosfomycin Trometamol Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Fosfomycin Trometamol Revenue Market Share by Company (2016-2021)
Table 78. Japan Fosfomycin Trometamol Sales by Type (2016-2021) & (K MT)
Table 79. Japan Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
Table 80. Japan Fosfomycin Trometamol Sales by Type (2022-2027) & (K MT)
Table 81. Japan Fosfomycin Trometamol Sales Market Share by Type (2022-2027)
Table 82. Japan Fosfomycin Trometamol Sales by Application (2016-2021) & (K MT)
Table 83. Japan Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
Table 84. Japan Fosfomycin Trometamol Sales by Application (2022-2027) & (K MT)
Table 85. Japan Fosfomycin Trometamol Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Fosfomycin Trometamol Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Fosfomycin Trometamol Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Fosfomycin Trometamol Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Fosfomycin Trometamol Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Fosfomycin Trometamol Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Fosfomycin Trometamol Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Fosfomycin Trometamol Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Fosfomycin Trometamol Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Fosfomycin Trometamol Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Fosfomycin Trometamol Sales Market Share by Application (2022-2027)
Table 98. India Fosfomycin Trometamol Sales (K MT) by Company (2016-2021)
Table 99. India Fosfomycin Trometamol Sales Market Share by Company (2016-2021)
Table 100. India Fosfomycin Trometamol Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Fosfomycin Trometamol Revenue Market Share by Company (2016-2021)
Table 102. India Fosfomycin Trometamol Sales by Type (2016-2021) & (K MT)
Table 103. India Fosfomycin Trometamol Sales Market Share by Type (2016-2021)
Table 104. India Fosfomycin Trometamol Sales by Type (2022-2027) & (K MT)
Table 105. India Fosfomycin Trometamol Sales Market Share by Type (2022-2027)
Table 106. India Fosfomycin Trometamol Sales by Application (2016-2021) & (K MT)
Table 107. India Fosfomycin Trometamol Sales Market Share by Application (2016-2021)
Table 108. India Fosfomycin Trometamol Sales by Application (2022-2027) & (K MT)
Table 109. India Fosfomycin Trometamol Sales Market Share by Application (2022-2027)
Table 110. Zambon Corporation Information
Table 111. Zambon Description and Business Overview
Table 112. Zambon Fosfomycin Trometamol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Zambon Fosfomycin Trometamol Product
Table 114. Zambon Recent Development
Table 115. Northesat Pharm Corporation Information
Table 116. Northesat Pharm Description and Business Overview
Table 117. Northesat Pharm Fosfomycin Trometamol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Northesat Pharm Fosfomycin Trometamol Product
Table 119. Northesat Pharm Recent Development
Table 120. Hunan Huana Pharmaceuticals Corporation Information
Table 121. Hunan Huana Pharmaceuticals Description and Business Overview
Table 122. Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Hunan Huana Pharmaceuticals Fosfomycin Trometamol Product
Table 124. Hunan Huana Pharmaceuticals Recent Development
Table 125. Xunda Pharma Corporation Information
Table 126. Xunda Pharma Description and Business Overview
Table 127. Xunda Pharma Fosfomycin Trometamol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Xunda Pharma Fosfomycin Trometamol Product
Table 129. Xunda Pharma Recent Development
Table 130. FarmaSino Pharmaceutical Corporation Information
Table 131. FarmaSino Pharmaceutical Description and Business Overview
Table 132. FarmaSino Pharmaceutical Fosfomycin Trometamol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. FarmaSino Pharmaceutical Fosfomycin Trometamol Product
Table 134. FarmaSino Pharmaceutical Recent Development
Table 135. Guilin Hwasun Corporation Information
Table 136. Guilin Hwasun Description and Business Overview
Table 137. Guilin Hwasun Fosfomycin Trometamol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Guilin Hwasun Fosfomycin Trometamol Product
Table 139. Guilin Hwasun Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Fosfomycin Trometamol Distributors List
Table 143. Fosfomycin Trometamol Customers List
Table 144. Fosfomycin Trometamol Market Trends
Table 145. Fosfomycin Trometamol Market Drivers
Table 146. Fosfomycin Trometamol Market Challenges
Table 147. Fosfomycin Trometamol Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Fosfomycin Trometamol Product Picture
Figure 2. Global Fosfomycin Trometamol Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Fosfomycin Trometamol Sales Market Share by Application in 2021 & 2027
Figure 6. Common Urinary Tract Infection Examples
Figure 7. Postoperative Urinary Tract Infection Examples
Figure 8. Preoperative Prevention of Urinary Tract Infection Examples
Figure 9. Global Fosfomycin Trometamol Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Fosfomycin Trometamol Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Fosfomycin Trometamol Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Fosfomycin Trometamol Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Fosfomycin Trometamol Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Fosfomycin Trometamol Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Fosfomycin Trometamol Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Fosfomycin Trometamol Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Fosfomycin Trometamol Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Fosfomycin Trometamol Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Fosfomycin Trometamol Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Fosfomycin Trometamol Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Fosfomycin Trometamol Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Fosfomycin Trometamol Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Fosfomycin Trometamol Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Fosfomycin Trometamol Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Fosfomycin Trometamol Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Fosfomycin Trometamol Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Fosfomycin Trometamol Players Market Share by Revenue in Fosfomycin Trometamol: 2016 & 2020
Figure 28. Fosfomycin Trometamol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Fosfomycin Trometamol Revenue Share by Type (2016-2021)
Figure 30. Global Fosfomycin Trometamol Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Fosfomycin Trometamol Revenue Share by Application (2016-2021)
Figure 32. Global Fosfomycin Trometamol Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Fosfomycin Trometamol Sales Market Share by Type in 2020
Figure 34. North America Fosfomycin Trometamol Sales Market Share by Application in 2020
Figure 35. Europe Fosfomycin Trometamol Sales Market Share by Type in 2020
Figure 36. Europe Fosfomycin Trometamol Sales Market Share by Application in 2020
Figure 37. China Fosfomycin Trometamol Sales Market Share by Type in 2020
Figure 38. China Fosfomycin Trometamol Sales Market Share by Application in 2020
Figure 39. Japan Fosfomycin Trometamol Sales Market Share by Type in 2020
Figure 40. Japan Fosfomycin Trometamol Sales Market Share by Application in 2020
Figure 41. Southeast Asia Fosfomycin Trometamol Sales Market Share by Type in 2020
Figure 42. Southeast Asia Fosfomycin Trometamol Sales Market Share by Application in 2020
Figure 43. India Fosfomycin Trometamol Sales Market Share by Type in 2020
Figure 44. India Fosfomycin Trometamol Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Fosfomycin Trometamol
Figure 47. Manufacturing Process Analysis of Fosfomycin Trometamol
Figure 48. Fosfomycin Trometamol Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed